Skip to main content
Premium Trial:

Request an Annual Quote

Biosite Partners with Neurocrine Biosciences in Antibody, Stroke Target Collaboration

NEW YORK, Feb. 20 - Biosite and Neurocrine Biosciences have signed a three-year research collaboration, the companies said today.


Under the agreement, Neurocrine will provide drug targets, and Biosite will use its phage display technology to generate antibodies to the targets. Biosite will get fees for antibodies when it delivers them to Neurocrine, as well as possible milestone fees, and diagnostic licenses to stroke targets to which Neurocrine has rights. Neurocrine will use the antibodies in its drug discovery research.


Biosite, which focuses on protein-based diagnostics, also has an antibody discovery collaboration agreement with Ciphergen and an agreement to developing protein chips with Large Scale Biology.


For more information on this collaboration, see the company statement.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.